Engineering CAR T cells to deliver endogenous RNA wakes solid tumors to respond to therapy — ScienceDaily
Chimeric antigen receptor (CAR) T cell therapy, which uses engineered T cells to treat certain types of cancers, has often been a challenging approach to treating solid tumors. CAR T…
